Literature DB >> 16548490

[Stevens-Johnson syndrome and toxic epidermal necrolysis after intake of rifampicin-isoniazid: report of 8 cases in HIV-infected patients in Togo].

P Pitche1, T Mouzou, C Padonou, K Tchangai-Walla.   

Abstract

Dermatological reactions are frequent drug-related complications in patients with HIV infection. The most serious disorders are Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), a.k.a. Lyell's syndrome, that are potentially fatal. The purpose of this report is to describe 8 cases of SJS/TEN observed in Lomé teaching hospital (Togo) after intake of a combination of rifampicin-isoniazid by HIV-infected patients. There were 5 men and 3 women with a mean age of 28 years. All patients presented AIDS. The disorder was SJS in 3 cases and TEN in 5. In 6 cases, manifestations occurred during initiation of treatment (mean delay for onset, 16 days). In the remaining two cases, manifestations occurred 6 days and 8 days respectively after beginning treatment for recurrent tuberculosis. Mean skin detachment was 8% in patients with SJS and 55.7% in patients with TEN. Five patients including 4 with TEN and 1 with SJS died. This study documents incrimination of combined rifampin-isoniazid treatment in the occurrence of SJS/TEN in patients with HIV infection and confirms the severity and poor prognosis of these disorders. The presence of opportunistic infections such as pulmonary tuberculosis may be an unfavourable prognostic factor in immunocompromised patients with these severe dermatological disorders.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16548490

Source DB:  PubMed          Journal:  Med Trop (Mars)        ISSN: 0025-682X


  5 in total

1.  Cutaneous adverse drug reactions in patients with peripheral blood eosinophilia during antituberculosis treatment.

Authors:  Tae-Ok Kim; Hong-Joon Shin; Yu-Il Kim; Sung-Chul Lim; Young-Il Koh; Yong-Soo Kwon
Journal:  Korean J Intern Med       Date:  2019-03-19       Impact factor: 2.884

Review 2.  An Update on Adverse Cutaneous Drug Reactions in HIV/AIDS.

Authors:  Koraisha Hoosen; Anisa Mosam; Ncoza Cordelia Dlova; Wayne Grayson
Journal:  Dermatopathology (Basel)       Date:  2019-06-26

3.  Severe Cutaneous Adverse Reactions to Anti-tuberculosis Drugs in Korean Patients.

Authors:  Hyun Jung Jin; Dong Yoon Kang; Young Hee Nam; Young Min Ye; Young Il Koh; Gyu Young Hur; Sae Hoon Kim; Min Suk Yang; Sujeong Kim; Yi Yeong Jeong; Min Hye Kim; Jeong Hee Choi; Hye Ryun Kang; Eun Jung Jo; Hye Kyung Park
Journal:  Allergy Asthma Immunol Res       Date:  2021-03       Impact factor: 5.764

4.  Response to Modified Antitubercular Drug Regime and Antiretroviral Therapy in a Case of HIV Infection with Disseminated Tuberculosis with Isoniazid Induced Toxic Epidermal Necrolysis.

Authors:  Abhijit Swami; Bhaskar Gupta; Prithwiraj Bhattacharjee
Journal:  Case Rep Infect Dis       Date:  2012-12-05

5.  Controversies in the Management of Cutaneous Adverse Drug Reactions.

Authors:  Yashpal Manchanda; Sudip Das; Aarti Sarda; Projna Biswas
Journal:  Indian J Dermatol       Date:  2018 Mar-Apr       Impact factor: 1.494

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.